Literature DB >> 12918100

Assessment of hepatic VX2 tumors of rabbits with second harmonic imaging under high and low acoustic pressures.

Wen-Hua Du1, Wei-Xiao Yang, Xiang Wang, Xiu-Qin Xiong, Yi Zhou, Tao Li.   

Abstract

AIM: To investigate the possible clinical application value of second harmonic imaging under low acoustic pressure.
METHODS: Six New Zealand rabbits, averaging 2.7+/-0.4 kg, were selected and operated upon to construct hepatic VX2 tumor carrier model. Hepatic VX2 tumors were imaged with B mode Ultrasonography (US), and second harmonic imaging (SHI) under high mechanic index (1.6) and low mechanic index (0.1). Echo agent was intravenously injected through ear vein at a dose of 0.01 mL/kg under B mode US and high MI SHI, and 0.05 mL/kg under low MI SHI, and then the venous channel was cleaned with sterilized saline. All the images were recorded by magnetic optics (MO), and they were analyzed further by at least two independent experienced sonographers.
RESULTS: Totally 6 hypoechoic and 3 hyperechoic lesions were found in the six carrier rabbits with a mean size about 2.1+/-0.4 under B mode ultrasound, they were oval or round in shape with a clear outline or a hypoechoic halo at the margin of the lesions. Contrast agent could not change the echogenicity of the lesions under B mode US and SHI under high acoustic pressure. However, it could greatly increase the real time visualization sensitivity of the lesions with SHI under low acoustic pressure.
CONCLUSION: Our results suggest that contrast enhanced SHI with low MI and a bubble non-destructive method would be much more helpful than conventional SHI in our future clinical applications.

Entities:  

Mesh:

Year:  2003        PMID: 12918100      PMCID: PMC4611523          DOI: 10.3748/wjg.v9.i8.1679

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Limitations of characterization of hepatic hemangiomas using a sonographic contrast agent (Levovist) and power Doppler ultrasonography.

Authors:  T K Kim; J K Han; A Y Kim; B I Choi
Journal:  J Ultrasound Med       Date:  1999-11       Impact factor: 2.153

Review 2.  Focal liver lesions: Doppler ultrasound.

Authors:  N Hosten; R Puls; W O Bechstein; R Felix
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

Review 3.  The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions.

Authors:  E Leen
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

4.  A prospective study of six methods for detection of hepatic colorectal metastases.

Authors:  R Carter; D Hemingway; T G Cooke; R Pickard; F W Poon; J A McKillop; C S McArdle
Journal:  Ann R Coll Surg Engl       Date:  1996-01       Impact factor: 1.891

5.  Ultrasound contrast enhancement of tumours.

Authors:  D Cosgrove
Journal:  Clin Radiol       Date:  1996-02       Impact factor: 2.350

6.  B-mode enhancement of the liver with microbubble contrast agent: a blinded study in rabbits with VX2 tumors.

Authors:  M S Girard; Y Kono; C B Sirlin; K G Baker; L H Deiranieh; R F Mattrey
Journal:  Acad Radiol       Date:  2001-08       Impact factor: 3.173

7.  Recent advances in ultrasonographic diagnosis of hepatocellular carcinoma.

Authors:  S Tanaka; T Kitamura; K Nakanishi; S Okuda; J Kojima; I Fujimoto
Journal:  Cancer       Date:  1989-04-01       Impact factor: 6.860

8.  Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US.

Authors:  C Bartolozzi; R Lencioni; P Ricci; A Paolicchi; P Rossi; R Passariello
Journal:  Radiology       Date:  1998-11       Impact factor: 11.105

9.  Parenchymal enhancement and tumor visualization using a new sonographic contrast agent.

Authors:  F Forsberg; J B Liu; D A Merton; N M Rawool; B B Goldberg
Journal:  J Ultrasound Med       Date:  1995-12       Impact factor: 2.153

10.  Hepatocellular carcinoma: sonographic and histologic correlation.

Authors:  S Tanaka; T Kitamura; S Imaoka; Y Sasaki; H Taniguchi; S Ishiguro
Journal:  AJR Am J Roentgenol       Date:  1983-04       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.